Quantitative Synthetic Human imm unodeficiency virus 1 (HIV-1) RNA 拉丁名
(ATCC® VR-3245SD™)統(tǒng)一編號
Strain 別名 Quantitative Synthetic Human imm unodeficiency virus 1 (HIV-1) RNA
Applications ATCC® Genuine Nucleics can be used for assay development, verification, validation, monitoring of day-to-day test variation and lot-to-lot performance of molecular-based assays. The quantitative format allows for the generation of a standard curve for quantitative PCR (qPCR) to determine viral load and for other molecular biology applications.
Biosafety Level生物安全等級 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 frozen
Specification range: 1 x 105 to 1 x 106 copies/µL
100 µL per vial with Biomatrica RNAstable
Storage Conditions 保藏條件 -70°C or colder
Intended Use The synthetically engineered sequence of the product constitutes intellectual property belonging to ATCC. Unauthorized use, including sequencing, modification, or reverse-engineering, of the product is expressly prohibited without prior ATCC consent.
Biomatrica Logo
Comments 注釋 Manufactured under ISO 13485 guidance
Preparation includes fragments from the 5' LTR, gag gene, pol gene (including protease, reverse transcriptase, and integrase regions), tat gene, rev gene, and nef gene.
This construct also includes clinically significant mutation profiles to allow compatibility with the CDC genotyping assay patent, including 41L, 67N, 70R, 103N, 181C, 215Y, and 90M. (Centers for Disease Control and Prevention. Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs. US Patent 8,592,146 dated Nov. 26, 2013)
The following primers and probe can be used with this nucleic acid preparation Ref:
Forward: TACTGACGCTCTCGCACC
Reverse: TCTCGACGCAGGACTCG
Probe: CTCTCTCCTTCTAGCCTC
Name of Depositor ATCC
U.S. Patent 8,592,146
U.S. Patent Number 8,592,146
Special Collection RNA
References 參考文獻(xiàn)
Henrich TJ, et al. Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J. Virol. Methods 186(1-2): 68-72, 2012. PubMed: 22974526
Centers for Disease Control and Prevention. Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs. US Patent 8,592,146 dated Nov. 26, 2013
固定電話:010-53515223
業(yè)務(wù)手機(jī):18610886853,18610241664,18701099593,18971386853,18701098095
微信號碼:vrmte521(18610886853企業(yè)微信);18610241664;biobw0905(18701098095)
企業(yè)公眾號:800185668
官方郵箱:biobw11@sina.com(微生物菌種查詢網(wǎng))
投訴電話:biobw8888(18701099593)